产品名称 | Imanis Life Sciences | CL191 | K562-Fluc-Puro/HuCD20-Neo |
---|---|
目录号 | CL191 |
别名 | K562-Fluc-Puro/HuCD20-Neo |
外观 | 见COA |
分子量 | N/A |
CAS | N/A |
溶解度 | |
存储条件 | 见COA |
保存时间 | 见COA |
备注1 | |
备注2 |
目录号 | 规格 | 价格 | 库存状态 | |
CL191 | 咨询 | 咨询 |
Imanis Life Sciences | CL191 | K562-Fluc-Puro/HuCD20-Neo
品名:K562-Fluc-Puro/HuCD20-Neo
货号:CL191
品牌:Imanis Life Sciences
产品描述
Species:Human
Cell Type:Chronic Myelogenous Leukemia
Transgene:Firefly luciferase (Fluc; Luc2)Human CD20 (HuCD20)
Selection Gene:Puromycin resistance (Puro)Neomycin resistance (Neo)
The K562-Fluc-Puro/HuCD20-Neo cell line stably expresses firefly luciferase and human CD20. The cells are designed for in vitro and in vivo studies of CD20. Parental K562-Fluc-Puro cells can be used as a negative control. Parental K562-Fluc-Puro cells (Imanis #CL171) cells were transduced with a human CD20-encoding lentivirus. A high HuCD20-expressing population was generated by selection using a methylcellulose based semi-solid medium. This cell line has been tested for mycoplasma contamination and is certified mycoplasma free. The parental K562 cell line was licensed and purchased directly from ATCC*. *The ATCC trademark and trade name and any and all ATCC catalog numbers are trademarks of the American Type Culture Collection.